Related Experiment Video
Updated: Jul 13, 2025

08:45
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.3K
Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS Medicinal Chemistry Letters
|October 18, 2023
Abstract:
Provided herein are novel pyrazolopyrazine compounds as SHP2 inhibitors, pharmaceutical compositions, use of such compounds in treating glioblastoma, and processes for preparing such compounds.

